Femasys Inc

FEMY

Company Profile

  • Business description

    Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

  • Contact

    3950 Johns Creek Court
    Suite 100
    SuwaneeGA30024
    USA

    T: +1 770 500-3910

    https://www.femasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    71

Stocks News & Analysis

stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,151.800.100.00%
CAC 408,333.8313.37-0.16%
DAX 4025,295.82124.84-0.49%
Dow JONES (US)48,940.89251.10-0.51%
FTSE 10010,157.3820.030.20%
HKSE26,999.81151.340.56%
NASDAQ23,430.46279.42-1.18%
Nikkei 22554,341.23792.071.48%
NZX 50 Index13,757.71101.660.74%
S&P 5006,907.2356.51-0.81%
S&P/ASX 2008,820.601.20-0.01%
SSE Composite Index4,126.0912.67-0.31%

Market Movers